Skip to main content
Immunology logoLink to Immunology
. 1985 Feb;54(2):317–324.

Comparative studies on adjuvanticity of Klebsiella O3 lipopolysaccharide and its lipid A and polysaccharide fractions.

N Kato, N Kido, M Ohta, S Naito
PMCID: PMC1453489  PMID: 3881339

Abstract

Previously, we found that Klebsiella O3 lipopolysaccharide (KO3 LPS) exhibits very strong adjuvant activity in augmenting the delayed-type hypersensitivity and antibody responses to protein antigens, and also strong ability to enlarge the regional lymph node in mice. By hydrolysis in 1% acetic acid at 100 degrees for 1 hr, KO3 LPS was dissociated into 54-60% polysaccharide fraction and 25-27% lipid A fraction. The lipid A fraction thus prepared retained lethal toxicity for mice, whereas the polysaccharide fraction was essentially non-toxic. However, neither the lipid A fraction nor the polysaccharide fraction could reproduce the strong adjuvanticity of KO3 LPS, and a simple mixture of these two fractions also failed to do so. It is therefore concluded that, for expression of the strong adjuvanticity of KO3 LPS, both the lipid A and polysaccharide moieties are indispensable and must be combined in the form of LPS. By contrast, administration of relatively large amounts of the lipid A fraction alone could elicit enlargement of the regional lymph node to the same degree as that attained by KO3 LPS. The regional lymph node-enlarging activity of the lipid A fraction in lesser amounts was enhanced by addition of the polysaccharide fraction. It is therefore likely that there is no direct correlation between adjuvant activity of the LPS or its derivatives, and their regional lymph node-enlarging activity.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curvall M., Lindberg B., Lönngren J., Nimmich W. Structural studies on the Klebsiella O group 3 lipopolysaccharide. Acta Chem Scand. 1973;27(7):2645–2649. doi: 10.3891/acta.chem.scand.27-2645. [DOI] [PubMed] [Google Scholar]
  2. Galanos C., Lüderitz O. Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem. 1975 Jun;54(2):603–610. doi: 10.1111/j.1432-1033.1975.tb04172.x. [DOI] [PubMed] [Google Scholar]
  3. Galanos C., Rietschel E. T., Lüderitz O., Westphal O. Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem. 1971 Mar 1;19(1):143–152. doi: 10.1111/j.1432-1033.1971.tb01298.x. [DOI] [PubMed] [Google Scholar]
  4. Hasegawa T., Ohta M., Mori M., Nakashima I., Kato N. The Klebsiella O3 lipopolysaccharide isolated from culture fluid: structure of the polysaccharide moiety. Microbiol Immunol. 1983;27(8):683–694. doi: 10.1111/j.1348-0421.1983.tb00631.x. [DOI] [PubMed] [Google Scholar]
  5. Kato N., Ohta M., Hasegawa T., Mori M., Yamaki K., Mizuta K., Nakashima I., Naito S. Further studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. II. Serological relationship between the adjuvant polysaccharide and O3 antigen of Klebsiella. Microbiol Immunol. 1981;25(12):1317–1325. doi: 10.1111/j.1348-0421.1981.tb00140.x. [DOI] [PubMed] [Google Scholar]
  6. Kato N., Ohta M., Kido N., Naito S., Kuno T. Ultrastructure of Klebsiella O3 lipopolysaccharide isolated from culture supernatant: structure of various uniform salt forms. Microbiol Immunol. 1984;28(5):559–567. doi: 10.1111/j.1348-0421.1984.tb00708.x. [DOI] [PubMed] [Google Scholar]
  7. Lindberg B., Lönngren J., Nimmich W. Structural studies on Klebsiella O group 5 lipopolysaccharides. Acta Chem Scand. 1972;26(6):2231–2236. doi: 10.3891/acta.chem.scand.26-2231. [DOI] [PubMed] [Google Scholar]
  8. Nakashima I., Kobayashi T., Kato N. Alterations in the antibody response to bovine serum albumin by capsular polysaccharide of Klebsiella pneumoniae. J Immunol. 1971 Oct;107(4):1112–1121. [PubMed] [Google Scholar]
  9. Ohta M., Mori M., Hasegawa T., Nagase F., Nakashima I., Naito S., Kato N. Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant. Microbiol Immunol. 1981;25(9):939–948. doi: 10.1111/j.1348-0421.1981.tb00098.x. [DOI] [PubMed] [Google Scholar]
  10. Ohta M., Mori M., Nakashima I., Kato N. Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. VII. Further purification of the active substance. Microbiol Immunol. 1979;23(8):805–813. doi: 10.1111/j.1348-0421.1979.tb00522.x. [DOI] [PubMed] [Google Scholar]
  11. Ohta M., Nakashima I., Kato N. Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. II. Relationships of intensity of the action to that of other immunological activities. Immunobiology. 1982 Dec;163(5):460–469. doi: 10.1016/S0171-2985(82)80060-0. [DOI] [PubMed] [Google Scholar]
  12. Ohta M., Nakashima I., Kato N. Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. Cell Immunol. 1982 Jan 1;66(1):111–120. doi: 10.1016/0008-8749(82)90162-9. [DOI] [PubMed] [Google Scholar]
  13. Prehm P., Jann B., Jann K. The O9 antigen of Escherichia coli. Structure of the polysaccharide chain. Eur J Biochem. 1976 Aug 1;67(1):53–56. doi: 10.1111/j.1432-1033.1976.tb10631.x. [DOI] [PubMed] [Google Scholar]
  14. Reske K., Jann K. The O8 antigen of Escherichia coli. Structure of the polysaccharide chain. Eur J Biochem. 1972 Dec 4;31(2):320–328. doi: 10.1111/j.1432-1033.1972.tb02536.x. [DOI] [PubMed] [Google Scholar]
  15. Westphal O. Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture. Int Arch Allergy Appl Immunol. 1975;49(1-2):1–43. [PubMed] [Google Scholar]
  16. Yokochi T., Nakashima I., Kato N. Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. VIII. Its effect on the size and the number of cells of regional lymph node and other lymphoid organs. Microbiol Immunol. 1980;24(2):141–154. doi: 10.1111/j.1348-0421.1980.tb00572.x. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES